152 related articles for article (PubMed ID: 34970416)
1. The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy.
Tang Z; Dong H; Li T; Wang N; Wei X; Wu H; Liu Y; Wang W; Guo Z; Xiao X
Oxid Med Cell Longev; 2021; 2021():5192271. PubMed ID: 34970416
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
Liu L; Geng H; Mei C; Chen L
Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
[TBL] [Abstract][Full Text] [Related]
5. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
6. Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression.
Hu K; Xie W; Ni S; Yan S; Tian G; Qi W; Duan Y
Oncol Rep; 2020 Aug; 44(2):650-660. PubMed ID: 32627005
[TBL] [Abstract][Full Text] [Related]
7. [Effect of ursolic acid on proliferation and apoptosis of human osteosarcoma cell line U2-OS].
Huang S; Cai F; Cheng Z; Zhou R; Hao L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2017 Nov; 31(11):1371-1376. PubMed ID: 29798594
[TBL] [Abstract][Full Text] [Related]
8. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
9. Combined Use of Zoledronic Acid Augments Ursolic Acid-Induced Apoptosis in Human Osteosarcoma Cells through Enhanced Oxidative Stress and Autophagy.
Wu CC; Huang YF; Hsieh CP; Chueh PJ; Chen YL
Molecules; 2016 Nov; 21(12):. PubMed ID: 27916903
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
Hu T; Fei Z; Wei N
Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
[TBL] [Abstract][Full Text] [Related]
11. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
Li Y; Xing D; Chen Q; Chen WR
Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.
Shan J; Xuan Y; Zhang Q; Zhu C; Liu Z; Zhang S
Protein Cell; 2016 Aug; 7(8):571-85. PubMed ID: 27472952
[TBL] [Abstract][Full Text] [Related]
15. Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Toxicol Lett; 2013 Aug; 221(3):197-204. PubMed ID: 23830991
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1α.
Zhao W; Xia SQ; Zhuang JP; Zhang ZP; You CC; Yan JL; Xu GP
Mol Cell Biochem; 2016 Sep; 420(1-2):1-8. PubMed ID: 27473145
[TBL] [Abstract][Full Text] [Related]
17. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
Tsai HC; Huang CY; Su HL; Tang CH
PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
[TBL] [Abstract][Full Text] [Related]
18. A new synthetic ursolic acid derivative IUA with anti-tumor efficacy against osteosarcoma cells via inhibition of JNK signaling pathway.
Chen J; Fu H; Wang Z; Yin F; Li J; Hua Y; Cai Z
Cell Physiol Biochem; 2014; 34(3):724-33. PubMed ID: 25171517
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]